Thus, because glucocorticoids increase ROS generation in metastatic B16 melanoma cells [6], we investigated whether the decrease in γ-GCS activity in iB16-shGCR metastatic cells is associated with changes in nuclear Nrf1 and/or Nrf2. Here, NFE2L2 is linked to melanoma.